Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Zadaxin thymosin alpha 1 data

SCLN (San Mateo, Calif.) reported to shareholders an interim analysis of a Phase

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE